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001: M. tb. PE/PPE family genes: Role in Quorom
sensing and modulating the host response
Seyed E. Hasnain
Center for DNA Fingerprinting and Diagnostics (CDFD),
Hyderabad 500 076, India
Death due to TB caused by the pathogen Mycobacterium tuberculosis
(M. tb.) accounts approximately for one death every 15 s somewhere in
the world. The most interesting outcome of the genome sequence data
of M. tb. was the presence of a large number of hypothetical genes or
those for which functions could only be ascribed based on homology
and also the presence of a small number (about 10%) of genes
belonging to the PE/PPE family which have no known homologues in
the living kingdom other than in the genus Mycobacteria. Molecular
epidemiology, evolutionary dynamics and the functional biology of M.
tb. has been the major interest of my group. We are focusing on genes
which are unknown, and also those known to have a function, with a
view to understand how M. tb. has evolved unique modalities to evade
the immune system. In the process we have additionally been able to
identify new diagnostic antigens and at the same time potential drug
targets. Our studies have also shown that immunology crosstalk’s
between host (human) and the pathogen (M. tb.) involve the use of
select members of the large PE and PPE proteins family as well as
other essential enzymes known to have non-immune function. My
presentation will focus on the host parasite interactions aimed at
crippling the host immune response which the pathogen (M. tb.) very
cleverly initiates for its own survival and dissemination.
003: Metagenomics of the human gut microbiome
Todd D. Taylor
MetaSystems Research Team, Computational Systems Biology
Research Group, Advanced Computational Sciences Department,
RIKEN Advanced Science Institute, 1-7-22 Suehiro-cho, Tsurumi-ku,
Yokohama, Kanagawa 230-0045, Japan
An enormous number of microorganisms, the vast majority of which are
bacteria, colonize and form specific communities (microbiota) at many
human body sites. The human microbiota, including the most abundant
gut microbiota, together with host cells forms a complex ecosystem that
collaboratively conducts various biological processes. Thus, we must
consider ourselves as ‘super organisms’ made up of both human cells and
our indigenous microbes, whose composite genome is referred to as the
human ‘metagenome’. The average human adult gut microbiota com-
prises 109–11 out of an estimated 1014 total commensal microbes per
individual, accounting for approximately 10 times the number of
eukaryotic cells in the human body. These gut microbiota are largely
associated with the metabolism processes necessary in human biology,
maturation and proliferation of host intestinal cells to maintain gut
homeostasis, and etiology of various diseases such as inflammatory bowel
diseases and obesity. The International Human Microbiome Consortium
(IHMC), which was launched in 2007, aims to collect and integrate the
genomic information of several medically important human microbio-
mes. To explore the genomic and functional features of complex
microbial communities, including those of uncultivable microbes, a
culture-independent metagenomic approach is necessary. Our group (The
Human Metagenome Consortium Japan; HMGJ) has analyzed the gut
microbiomes of 13 healthy Japanese individuals, including adults,
weaned children, and unweaned infants. We generated about 1 million
Sanger reads accounting for unique metagenomic sequences totalling
479 Mb and predicted about 660,000 bacterial genes in them. By
searching for the genes significantly enriched in gut microbiomes in
contrast with those present in non-gut microbiomes, we identified 315
enriched gene families in these 13 human microbiomes. Analysis of their
predicted functions indicated the abundance of functions involved in
carbohydrate metabolism as well as many conserved gene families of
unknown function, suggesting that these gene sets may encode the core
functions necessary to adapt to the gut habitat. We also identified 647
novel gene families specific to human gut microbiomes by comparing
with genes present in the metagenomic data of other microbial commu-
nities such as sea-surface, deep-sea and soil. The IHMC, including the
activities of HMGJ, will further promote this research field and pave the
way to a new frontier of human biology which is expected to develop new
strategies for actively sustaining human health.
004: From bench to bedside to populations: Translation
of CCL3L1-CCR5 genetics for prevention
and management of HIV-AIDS
Sunil K. Ahuja
University of Texas Health Science Center at San Antonio, 7703
Floyd Curl Dr, San Antonio, TX 78229, United States of America
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Borrowing from Shakespeare, (William Shakespeare, and King
Richard II. Act ii. Sc. 1) ‘‘…this other Eden, demi-paradise, this
fortress built by Nature for herself against infection…’’
Nature’s fortress against infections such as HIV by necessity
involves host factors that influence the early events of HIV-host
interactions. In this seminar, I will show how we have used a genetic
approach as a powerful tool to identify the host factors that underlie
some of these early events. This approach has therefore permitted us
to address the following clinical paradoxes: Why do some individuals
when exposed to HIV-1 resist infection? Why do some individuals
succumb to HIV-1 infection rapidly whereas others resist progression
to AIDS? Why do some individuals have a better recovery of immune
function after initiation of HAART?
Using this genetic approach we have (a) uncovered complex host
gene–gene interactions that influence HIV-1 pathogenesis in vivo; (b)
determined the relative contribution of some of these host genetic
determinants to the HIV-1 epidemic at the population level. Specifi-
cally, in this seminar, I will focus on the role of CCR5 and its ligands
in HIV/AIDS pathogenesis. In previous studies we uncovered some of
the the CCR5 genetic determinants that contribute to inter-subject
differences in HIV/AIDS susceptibility. Here, I will show that there
are significant interindividual and interpopulation differences in the
copy number of a segmental duplication encompassing the gene
encoding CCL3L1 (MIP-1aP), a potent HIV-1-suppressive chemo-
kine and ligand for the HIV coreceptor CCR5. Possession of a
CCL3L1 copy number lower than the population average is associ-
ated with markedly enhanced HIV/AIDS susceptibility. This
susceptibility is even greater in individuals who also possess disease-
accelerating CCR5 genotypes. This relationship between CCL3L1
dose and altered HIV/AIDS susceptibility points to a central role for
CCL3L1 in HIV/AIDS pathogenesis. I will show that these genetic
factors influence HIV pathogenesis by affecting both viral entry-
dependent and -independent processes, one of which we identify
as cell-mediated immunity. I will then place these findings in the
broader context of issues relevant to the epidemic/vaccines as well as
individual-specific issues such as whether these variants have rele-
vance for understanding the inter-subject differences in response to
antiretroviral therapy.
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